Literature DB >> 2203607

Retrovirus phylogeny and evolution.

R F Doolittle1, D F Feng, M A McClure, M S Johnson.   

Abstract

The elucidation of complete genomic sequences from a wide variety of retroviruses and retrotransposons has allowed the construction of sequence-based phylogenies that reveal their evolutionary history. True retroviruses, whether exogenous or endogenous, tend to cluster into four major groups. Not only is there no distinction between exogenous and endogenous viruses, but their evolutionary limb lengths on the phylogenetic trees are comparable. This can be taken as evidence favoring a dynamic equilibrium balancing a constant invasion of germlines by infectious retroviruses on the one hand, with subsequent escape of endogenous viruses to alternative hosts on the other. Retroviruses share a common ancestry with a wide variety of retrotransposons and other reverse transcriptase-bearing entities. One of these retrotransposon groups, the Gypsy group, resembles the Moloney mouse group of retroviruses much more closely than it does other retroviruses. The simplest explanation is that the evolutionary rate of the retrotransposon is much slower than the retrovirus rate and that among the retroviruses the Moloney mouse group has been evolving more slowly than the other three groups, leaving the two short-limbed taxa more similar. The alternative explanation that these two groups actually shared a common ancestor more recently than has either with the other retrovirus groups is not supported by residue-by-residue character assessment.

Entities:  

Mesh:

Year:  1990        PMID: 2203607     DOI: 10.1007/978-3-642-75218-6_1

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  13 in total

Review 1.  The evolution, distribution and diversity of endogenous retroviruses.

Authors:  Robert Gifford; Michael Tristem
Journal:  Virus Genes       Date:  2003-05       Impact factor: 2.332

2.  Comparative analysis of the retroviral pol and env protein sequences reveal different evolutionary trees.

Authors:  G Lewe; R M Flügel
Journal:  Virus Genes       Date:  1990-02       Impact factor: 2.332

3.  Easel, a gypsy LTR-retrotransposon in the Salmonidae.

Authors:  M Tristem; P Kabat; E Herniou; A Karpas; F Hill
Journal:  Mol Gen Genet       Date:  1995-11-15

4.  Three retroviral sequences in amphibians are distinct from those in mammals and birds.

Authors:  M Tristem; E Herniou; K Summers; J Cook
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

5.  Identification, phylogeny, and evolution of retroviral elements based on their envelope genes.

Authors:  L Bénit; P Dessen; T Heidmann
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Computer-assisted prediction, classification, and delimitation of protein binding sites in nucleic acids.

Authors:  K Frech; G Herrmann; T Werner
Journal:  Nucleic Acids Res       Date:  1993-04-11       Impact factor: 16.971

7.  Transgenic cattle produced by reverse-transcribed gene transfer in oocytes.

Authors:  A W Chan; E J Homan; L U Ballou; J C Burns; R D Bremel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

8.  Retroviral diversity and distribution in vertebrates.

Authors:  E Herniou; J Martin; K Miller; J Cook; M Wilkinson; M Tristem
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Analysis of the murine ecotropic leukemia virus receptor reveals a common biochemical determinant on diverse cell surface receptors that is essential to retrovirus entry.

Authors:  S Malhotra; A G Scott; T Zavorotinskaya; L M Albritton
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.

Authors:  T J Palker; E R Riggs; D E Spragion; A J Muir; R M Scearce; R R Randall; M W McAdams; A McKnight; P R Clapham; R A Weiss
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.